Partnering 3.0 SAS designs and develops robotic technology. Its products include Diya One X and Diya One. The firm also provides Diya board and Diya dock. The company was founded by Ramesh Caussy in 2007 and is headquartered in Cergy, France.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS.\nKeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany.

Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases. Its product pipeline comprises ND-1004, a natural product based neuro-protectant for early-stage treatment of Parkinson's disease. It was founded in 2009 and is headquartered in Vancouver, British Columbia.

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

IMTM GmbH is engaged in the development of therapeutic drugs for the treatment of immune dysfunction diseases and conditions. The firm specializes in silico, in vitro, and in vivo methods that focus on the discovery, optimization, and analysis of drug candidates. Its service areas encompass drug design, pharmaceutical development, experimental medicine research, clinical trials, and laboratory testing. The company was founded in 1996 and is headquartered in Magdeburg, Germany.

Rio Grande Neurosciences manufactures pulsed electromagnetic field therapy devices for the treatment of neuroinflammation. The company develops traumatic brain injury therapeutics current disposable clinical treatment units, and devices for concussion clinical trials. Rio Grande Neurosciences was founded in 2011 and is based in San Francisco, California.

Shenyang Institute of Automation (Chinese: 沈阳自动化研究所) of the Chinese Academy of Sciences (CAS) was founded in 1958. It is mainly engaged in mechatronic engineering, pattern recognition and intelligent system, control theory and control engineering, computer applied technology.

Tianjin Medical University General Hospital (Chinese: 天津医科大学总医院) is a general hospital in the central Heping District of the Chinese metropolis of Tianjin, associated with Tianjin Medical University.